AU4858796A - Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders - Google Patents

Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Info

Publication number
AU4858796A
AU4858796A AU48587/96A AU4858796A AU4858796A AU 4858796 A AU4858796 A AU 4858796A AU 48587/96 A AU48587/96 A AU 48587/96A AU 4858796 A AU4858796 A AU 4858796A AU 4858796 A AU4858796 A AU 4858796A
Authority
AU
Australia
Prior art keywords
acid
phenylalkenoic
phenylalkanoic
ethyl esters
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48587/96A
Other languages
English (en)
Inventor
Saul W. Brusilow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23519346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4858796(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU4858796A publication Critical patent/AU4858796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU48587/96A 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders Abandoned AU4858796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38493595A 1995-02-02 1995-02-02
US384935 1995-02-07
PCT/US1996/000940 WO1996024571A1 (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Publications (1)

Publication Number Publication Date
AU4858796A true AU4858796A (en) 1996-08-27

Family

ID=23519346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48587/96A Abandoned AU4858796A (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Country Status (9)

Country Link
US (3) US5968979A (enExample)
EP (1) EP0858441B1 (enExample)
AT (1) ATE201013T1 (enExample)
AU (1) AU4858796A (enExample)
CA (1) CA2212047C (enExample)
DE (1) DE69612755T2 (enExample)
ES (1) ES2157422T3 (enExample)
FR (1) FR16C0003I2 (enExample)
WO (1) WO1996024571A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642543B1 (en) 2000-09-26 2003-11-04 The Board Of Trustees Of The Leland Stanford Junior University Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20040229948A1 (en) * 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
US20030195255A1 (en) * 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US20090260743A1 (en) * 2003-11-21 2009-10-22 William David Mawby Tire manufacturing method for improving the uniformity of a tire
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors
US8642012B2 (en) 2008-04-29 2014-02-04 Hyperion Therapeutics, Inc. Methods of treatment using ammonia-scavenging drugs
ES2593378T3 (es) * 2008-08-29 2016-12-09 Horizon Therapeutics, Llc Métodos de tratamiento usando fármacos de secuestro de ammonia
BR112014007357B1 (pt) 2011-09-30 2022-12-06 Immedica Pharma Ab Método para determinar o ajuste da dosagem de um fármaco de varredura de nitrogênio
SG11201406745VA (en) 2012-04-20 2014-12-30 Hyperion Therapeutics Inc Methods of therapeutic monitoring of phenylacetic acid prodrugs
WO2014081977A1 (en) 2012-11-21 2014-05-30 Bruce Scharschmidt Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
SI2986325T1 (sl) 2013-10-14 2020-02-28 Immedica Pharma Ab Postopki zdravljenja motenj ciklusa sečnine
IN2013MU03442A (enExample) 2013-10-30 2015-07-17 Lupin Ltd
MX383005B (es) 2013-11-14 2025-03-13 Ultragenyx Pharmaceutical Inc Composiciones solidas de trigliceridos y usos de estas.
JP6302091B2 (ja) 2014-04-30 2018-03-28 ザ・ジョンズ・ホプキンス・ユニバーシティー デンドリマー組成物および眼の疾患の処置におけるその使用
JP6342575B2 (ja) 2014-08-13 2018-06-13 ザ・ジョンズ・ホプキンス・ユニバーシティー 脳腫瘍への選択的デンドリマー送達
WO2017075580A1 (en) 2015-10-29 2017-05-04 The Johns Hopkins University Compositions and methods for treatment of peroxisomal disorders and leukodystrophies
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
JP7759322B2 (ja) 2019-12-04 2025-10-23 アシュバッタ セラピューティクス， インコーポレイテッド 眼に薬物送達するためのデンドリマー組成物および方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Also Published As

Publication number Publication date
ES2157422T3 (es) 2001-08-16
US6083984A (en) 2000-07-04
US5968979A (en) 1999-10-19
EP0858441A1 (en) 1998-08-19
CA2212047A1 (en) 1996-08-15
EP0858441A4 (enExample) 1998-08-19
FR16C0003I2 (fr) 2016-06-24
WO1996024571A1 (en) 1996-08-15
FR16C0003I1 (enExample) 2016-03-25
EP0858441B1 (en) 2001-05-09
CA2212047C (en) 2010-11-16
ATE201013T1 (de) 2001-05-15
DE69612755T2 (de) 2001-08-23
DE69612755D1 (de) 2001-06-13
US6060510A (en) 2000-05-09

Similar Documents

Publication Publication Date Title
AU4858796A (en) Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders
ZA9610508B (en) Pharmaceutical composition comprising l-carnitine or alkanoyl l-carnitine for the prevention and treatment of diseases brought about by lipid metabolism disorders
IL111251A0 (en) Compositions and methods for therapy and prevention of pathologies, including cancer, aids, and anemia
AU6171796A (en) Prodrugs of pharmaceuticals with improved bioavailability
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
ATE319447T1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
DE69805846D1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
NZ279062A (en) Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer
DK1586322T3 (da) Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
HRP20030879A2 (en) Pharmaceutically active uridine esters
WO2001017517A3 (en) Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer
PT1246625E (pt) Utilizacoes e composicoes de esteres de nitrato para proporcionar sedacao
AU4024797A (en) Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
PT977560E (pt) Tioesteres de ibuprofeno como inibidores de formacao de mediadores de inflamacaoe da dor dependente de nf-kb
MXPA02006610A (es) Sustancias para uso al tratar psoriasis.
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
NO932843L (no) Farmasoeytiske preparater
NZ292388A (en) S-enantiomers of 2-alkyl substituted pentynoic acid derivatives, preparation and pharmaceutical compositions thereof
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
IT1277118B1 (it) Composizioni farmaceutiche per il trattamento delle epatopatie croniche